Femara Drawing (Femara 01)
Femara Tablet, Film Coated
Product Images NDC 0078-0249
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Femara (NDC 0078-0249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Femara 02)
This is a chart or table displaying the results of a study comparing the use of Letrozole and Tamoxifen treatments in a group of 2463 and 2459 patients respectively. The table displays the number of events observed, the percentage of patients affected, and the percentage of patients censored for each group over a period of 72 months. The table also includes a graph displaying the number of patients at risk over the duration of the study for each group.*
Femara Fig2 (Femara 03)
Femara Fig 3 (Femara 04)
Femara Fig 4 (Femara 05)
Femara Fig 5 (Femara 06)
This is a table showing the time to progression (in days) for two different doses of a medication called Femara® and an "AG" treatment. No further information is available.*
Principal Display Panel – Package Label – 2.5 mg Tablets (Femara 07)
This is a prescription medicine produced by the company Novartis, primarily used for the treatment of breast cancer in postmenopausal women. The tablets contain 2.5mg of Letrozole each, and the package comes with 30 tablets. The code on the package is 078-0249-5 and the lot number is 101489957. Some text appears to be missing or unreadable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
